ADMA

ADMA Biologics
ADMA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$4.97B
EV
$4.98B
Shares Outstanding
243.91M
Beta
0.47

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$29.49
P/E 2025E
31.69x
P/Revenue 2025E
9.66x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ADMA Biologics, Inc.

gainify
ADMA

ADMA Biologics, Inc.

ADMA

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVI...

Sector

Healthcare

Industry

Biotechnology

CEO

Grossman, Adam

Employees

685

IPO Date

2013-10-17

Headquarters

465 State Route 17, Ramsey, New Jersey, 07446, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.